Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04951583 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Fecal Microbial Transplantation Non-Small Cell Lung Cancer and Melanoma

Study acronym: FMT-LUMINATE
StatusUnknown
PhasePhase 2
Started2021-11-16
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 7, 2024 (before its estimated September 1, 2024 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06
Trial status changed: Active, Not Recruiting → Unknown
2024-08-05
Study Status, Contacts/Locations v12
Trial statusActive, Not Recruiting→Unknown
2024-02-19
Recruiting→Active, Not Recruiting Study Status, Study Design, Contacts/Locations v11
Trial statusRecruiting→Active, Not Recruiting
Study sites4→6
2024-02-06
Study Status, Study Design v10
Enrollment target70→45
2023-08-30
Study Identification, Study Status v9
Re-verified, no change to tracked fields
Show 8 earlier versions
2022-08-19
Study Status, Contacts/Locations v8
Study sites3→4
2022-07-18
Study Status v7
Re-verified, no change to tracked fields
2022-06-16
Study Status, Contacts/Locations v6
Study sites2→3
2022-04-29
Study Status, Contacts/Locations v5
Study sites1→2
2021-12-09
Not Yet Recruiting→Recruiting Study Status, Arms and Interventions, Contacts/Locations v4
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2021-11-01→confirmed 2021-11-16
Study sitesdetails revised at 1 of 1 site
2021-09-22
Study Status v3
Start date2021-09-01→2021-11-01
2021-07-15
Study Identification, Study Status v2
Study title-18 characters
Phase II Trial of Fecal Microbial Transplantation Non-Small Cell Lung Cancer and Melanoma
2021-07-12
Study Identification, Study Status v1
Study title+1 characters
Phase IITrialII Trial of Fecal Microbial Transplantation Non-Small Cell Lung Cancer and Melanoma
2021-07-06
Original filing
The aim of this study is to assess the anti-tumor activity of FMT administered in combination with ICI therapy.
Trial Details
NCT Number NCT04951583
Lead Sponsor Centre hospitalier de l'Université de Montréal (CHUM)
Conditions Non Small Cell Lung Cancer Metastatic, Advanced Melanoma
Enrollment 45 participants
Start Date 2021-11-16
Primary Completion 2024-09-01 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-07